Emerging incretin and multi agonist based treatments the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio kidney liver metabolic diseases and beyond Metabolism Clinical and Experimental Mazdutide and Tirzepatide: How These Dual Pathway Weight Loss Drugs Really Compare Peptides Unleashed In Chinese adults with overweight or obesity, once weekly #GLP glucagon agonist mazdutide, at a dose of 4 mg or 6 mg for 32 48 weeks, led to clinically relevant #weightloss in the Mazdutide 5mg Dosage Protocol PeptideDosages.com Incretin based therapies for the treatment of obesity related diseases npj Metabolic Health and Disease Cagrilintide 3mg, Semaglutide 3mg Blend (SALE!) Polaris Peptides